[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100574360":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":33,"collaborators":10,"id":35,"slug":10,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":10,"eligibilityCriteria":40,"healthyVolunteers":36,"sex":41,"minAge":10,"maxAge":10,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},{"fullName":5,"class":6},"Kissei Pharmaceutical Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Avacopan treatmented",null,[12],"Drug: Avacopan",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Avacopan","oral administration",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Kazunori Abe, director","CONTACT","0356843575","rinsyousiken@pharm.kissei.co.jp",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"cosmosGeoPoint":10,"geoPoint":10,"contacts":31},"Research site","RECRUITING","Multiple Locations","Japan",[32],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":34,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100574360",false,"NCT06758271","Special Drug Use-results Survey for Long-term Use（Avacopan）","Special Drug Use-results Survey for Long-term Use","Inclusion Criteria:\n\n* Patients with granulomatosis with polyangiitis or microscopic polyangiitis who are treatment with avacopan","ALL",{"count":43,"type":44},250,"ESTIMATED","2 Years","OBSERVATIONAL","The purpose of this survey is evaluating the safety and efficacy of long-term administration of avacopan for Japanese patients with microscopic polyangiitis or granulomatosis with polyangiitis under actual conditions of use.",[49,50],"Microscopic Polyangiitis (MPA)","Granulomatosis With Polyangiitis (GPA)","2025-01-15",{"date":53,"type":54},"2025-01-17","ACTUAL",{"date":56,"type":54},"2022-07-29",{"date":58,"type":44},"2028-05-31",{"name":5,"class":6},1]